Plain-English translation of NCT06764875 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called combined with two other cancer drugs against the current standard treatment for advanced stomach cancer. The study will enroll about 840 people worldwide to see if this new combination works better and is safer than the treatment doctors typically use right now.
Advanced stomach cancer is very difficult to treat, and doctors are looking for better options. This medication is being tested because early research suggests it may help the immune system fight the cancer more effectively when combined with other treatments.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive one of three treatment combinations, either as an infusion or pill. You would visit the hospital or clinic regularly for treatment, blood tests, and scans to check how well the medication is working. The study continues until your disease gets worse or you experience side effects that require stopping treatment, which typically takes several months to a year or longer.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States